Cancer Biology Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology, Guwahati, Assam 781 039, India.
Stem Cell and Cancer Biology Laboratory, School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, West Australia 6009, Australia.
Phytomedicine. 2017 Feb 15;25:118-127. doi: 10.1016/j.phymed.2016.12.002. Epub 2016 Dec 12.
The risk of suffering from many chronic diseases seems to have made no improvement despite the advancement in medications available in the modern world. Moreover, the use of synthetic chemicals as medications has proved to worsen the scenario due to the various adverse side effects associated with them.
Extensive research on natural medicines provides ample evidence on the safety and efficacy of phytochemicals and nutraceuticals against diverse chronic ailments. Therefore, it is advisable to use natural products in the management of such diseases. This article aims to present a comprehensive and critical review of known pharmacological and biological effects of butein, an important chalcone polyphenol first isolated from Rhus verniciflua Stokes, implicated in the prevention and treatment of various chronic disease conditions.
An extensive literature search was conducted using PubMed, ScienceDirect, Scopus and Web of Science core collections using key words followed by evaluation of the bibliographies of relevant articles.
Butein has been preclinically proven to be effective against several chronic diseases because it possesses a wide range of biological properties, including antioxidant, anti-inflammatory, anticancer, antidiabetic, hypotensive and neuroprotective effects. Furthermore, it has been shown to affect multiple molecular targets, including the master transcription factor nuclear factor-κB and its downstream molecules. Moreover, since it acts on multiple pathways, the chances of non-responsiveness and resistance development is reduced, supporting the use of butein as a preferred treatment option.
Based on numerous preclinical studies, butein shows significant therapeutic potential against various diseases. Nevertheless, well-designed clinical studies are urgently needed to validate the preclinical findings.
尽管现代世界的药物有了进步,但许多慢性疾病的患病风险似乎并没有改善。此外,由于与合成化学品相关的各种不良反应,将它们用作药物反而使情况恶化。
对天然药物的广泛研究为植物化学物质和营养保健品针对各种慢性疾病的安全性和有效性提供了充分的证据。因此,在这类疾病的治疗中使用天然产品是明智的。本文旨在全面而批判性地综述源于漆树 Rhus verniciflua Stokes 的查尔酮多酚化合物——补骨脂素,其在预防和治疗各种慢性疾病方面的已知药理学和生物学作用。
使用 PubMed、ScienceDirect、Scopus 和 Web of Science 核心合集,通过关键词进行了广泛的文献检索,随后对相关文章的参考文献进行了评估。
补骨脂素已在临床前被证明对多种慢性疾病有效,因为它具有广泛的生物学特性,包括抗氧化、抗炎、抗癌、抗糖尿病、降压和神经保护作用。此外,它已被证明可以影响多种分子靶点,包括转录因子核因子-κB 及其下游分子。此外,由于它作用于多个途径,因此降低了无反应和耐药性发展的可能性,支持将补骨脂素用作首选治疗方案。
基于大量的临床前研究,补骨脂素对各种疾病显示出显著的治疗潜力。然而,迫切需要精心设计的临床试验来验证临床前研究结果。